Home         Forums  

Go Back   Marrowforums > Treatments > Transfusions and Iron Overload
Register FAQ Search Today's Posts Mark Forums Read

Transfusions and Iron Overload Blood and platelet transfusions, iron testing and treatments

Reply
 
Thread Tools Search this Thread
  #1  
Old Wed Dec 15, 2010, 05:51 PM
akita akita is offline
Member
 
Join Date: Nov 2010
Posts: 110
ASH 2010 ICT with DFX in Transfusion Dependent MDS

2928 Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial

http://ash.confex.com/ash/2010/webpr...aper32194.html

"Patients started treatment with the standard 20 mg/kg Deferasirox dose but dose adjustments on clinical indications were allowed." The duration of the treatment was 1 year.

"61 patients (49%) prematurely interrupted the study (drop out), 62 (51%) patients completed the planned year of treatment."

Discussion: "Preliminary results from the GIMEMA MDS0306 study confirmed feasibility of Deferasirox therapy in transfusion dependent MDS patients. Drop out rate, toxicity related drop out and severe side effects were similar to those reported in other trials even if the present population presented clinical characteristics of more advanced disease and age. The rate of progression is coherent with prolonged disease story. Serum ferritin behavior confirms Deferasirox efficacy. The serum ferritin reduction was more evident in the more heavily overloaded population indicating successful iron depletion in this group of patients as clinically requested."
__________________
Margarete, 54, living in Vienna, Austria,
MDS/AML M2, diagnosed 9/2007, then Chemos, aSZT 4/2008, chronic GVHD
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
ASH 2010 Lenalidomide in MDS with Karyotypes other than del 5q and Refractory to ESAs akita News and Events 0 Thu Dec 16, 2010 02:25 PM
ASH 2010 Splenectomy in Patients with MDS akita MDS 0 Thu Dec 16, 2010 01:46 PM
ASH 2010 Highly Transfused MDS Patients Often Have Cardiac Iron Overload akita Transfusions and Iron Overload 0 Wed Dec 15, 2010 05:21 PM
ASH 2010 Hematologic Responses in MDS Patients - Deferasirox/Exjade akita Transfusions and Iron Overload 0 Fri Dec 10, 2010 04:14 PM


All times are GMT -4. The time now is 09:45 PM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright 2006-2019 Marrowforums.org